Home > Annual Financials > 3B BLACKBIO DX

3B BLACKBIO DX Financial Statement Analysis
[BOM: 532067|NSE : 3BBLACKBIO]

The Revenues of 3B BLACKBIO DX have increased by 47.11% YoY .
The Earnings Per Share (EPS) of 3B BLACKBIO DX has increased by 25.66 % YoY.
COMMUNITY POLL
for 3B BLACKBIO DX
Please provide your vote to see the results

3B BLACKBIO DX Last 5 Annual Financial Results
[BOM: 532067|NSE : 3BBLACKBIO]

ConsolidatedMar2026
Mar2025
Mar2024
Mar2023
Mar2022
Revenues ₹142 Cr₹96 Cr₹74 Cr₹62 Cr₹81 Cr
Expenses ₹85 Cr₹46 Cr₹41 Cr₹33 Cr₹44 Cr
Operating Profit (Excl OI) ₹57 Cr₹50 Cr₹33 Cr₹29 Cr₹37 Cr
Other Income ₹26 Cr₹15 Cr₹13 Cr₹7.26 Cr₹6.90 Cr
Interest ₹0.24 Cr₹0.11 Cr₹0.13 Cr₹0.20 Cr₹0.11 Cr
Depreciation ₹5.13 Cr₹1.09 Cr₹1.06 Cr₹0.86 Cr₹0.67 Cr
Profit Before Tax ₹77 Cr₹64 Cr₹44 Cr₹35 Cr₹43 Cr
Profit After Tax ₹60 Cr₹48 Cr₹32 Cr₹26 Cr₹32 Cr
Consolidated Net Profit ₹60 Cr₹48 Cr₹32 Cr₹26 Cr₹32 Cr
Earnings Per Share (Rs)₹69.94₹55.66₹37.46₹30.28₹42.98
PAT Margin (%)42.2349.4443.3141.9439.93
ROE(%)20.2219.4115.4214.9822.59
ROCE(%)25.9026.0321.2120.2429.92
Total Debt/Equity(x)0.010.000.000.010.02

Key Financials

Market Cap : ₹ 1,317.7 Cr
Revenue (TTM) : ₹ 153.2 Cr
Net Profit(TTM) : ₹ 56.3 Cr
EPS (TTM) : ₹ 65.4
P/E (TTM) : 23.4

Industry Peers & Returns1W1M1Y
3B BLACKBIO DX -7.4% 0.7% 15.2%
LENSKART SOLUTIONS -5.4% -4.9% NA
POLY MEDICURE -2.3% -5.9% -17.2%
LAXMI DENTAL -0.7% -2.8% -39.8%
PREVEST DENPRO 0.9% -2.9% -26.1%
NURECA -5.1% 2.4% 44.2%


3B BLACKBIO DX Revenues
[BOM: 532067|NSE : 3BBLACKBIO]

Y-o-Y

47.11 %

5 Yr CAGR

15.18 %

Years Revenues % Change
Mar2026 ₹142 Cr
47.11
Mar2025 ₹96 Cr
30.14
Mar2024 ₹74 Cr
19.87
Mar2023 ₹62 Cr
-23.32
Mar2022 ₹81 Cr -


3B BLACKBIO DX Operating Profit
[BOM: 532067|NSE : 3BBLACKBIO]

Y-o-Y

13.30 %

5 Yr CAGR

11.22 %

Years Operating Profit % Change
Mar2026 ₹57 Cr
13.30
Mar2025 ₹50 Cr
51.93
Mar2024 ₹33 Cr
13.30
Mar2023 ₹29 Cr
-21.53
Mar2022 ₹37 Cr -

Operating Margins
Y-o-Y

-22.99 %

5 Yr CAGR

-3.43 %

Years Operating Margin% % Change
Mar2026 40%
-22.99
Mar2025 51.94%
16.75
Mar2024 44.49%
-5.50
Mar2023 47.08%
2.35
Mar2022 46% -

3B BLACKBIO DX Profit After Tax
[BOM: 532067|NSE : 3BBLACKBIO]

Y-o-Y

25.66 %

5 Yr CAGR

16.80 %

Years Profit After Tax % Change
Mar2026 ₹60 Cr
25.66
Mar2025 ₹48 Cr
48.57
Mar2024 ₹32 Cr
23.77
Mar2023 ₹26 Cr
-19.45
Mar2022 ₹32 Cr -

PAT Margins
Y-o-Y

-14.58 %

5 Yr CAGR

1.41 %

Years PAT Margin(%) % Change
Mar2026 42.23 %
-14.58
Mar2025 49.44 %
14.15
Mar2024 43.31 %
3.27
Mar2023 41.94 %
5.03
Mar2022 39.93 % -

3B BLACKBIO DX Earnings Per Share (EPS)
[BOM: 532067|NSE : 3BBLACKBIO]

Y-o-Y

25.66 %

5 Yr CAGR

12.94 %

Years EPS % Change
Mar2026 ₹70
25.66
Mar2025 ₹56
48.59
Mar2024 ₹37
23.71
Mar2023 ₹30
-29.55
Mar2022 ₹43 -

3B BLACKBIO DX Return on Capital Employed (ROCE)
[BOM: 532067|NSE : 3BBLACKBIO]

Y-o-Y

-0.50 %

5 Yr CAGR

-3.54 %

Years ROCE % Change
Mar2026 25.9%
-0.50
Mar2025 26.03%
22.73
Mar2024 21.21%
4.79
Mar2023 20.24%
-32.35
Mar2022 29.92% -

3B BLACKBIO DX Share Price vs Sensex

Current Share Price : ₹1,532.3
Current MarketCap: ₹ 1,317.7 Cr
Updated EOD on :Oct 08,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
3B BLACKBIO DX

-7.4%

0.7%

15.2%

SENSEX

-1.2%

-6.4%

-10.8%

3B BLACKBIO DX related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE -3.1% -4.7% 12.6%
No NSE index found

You may also like the below Video Courses


FAQ about 3B BLACKBIO DX Financials


How the annual revenues of 3B BLACKBIO DX have changed ?

The Revenues of 3B BLACKBIO DX have increased by 47.11% YoY .

How the Earnings per Share (EPS) of 3B BLACKBIO DX have changed?

The Earnings Per Share (EPS) of 3B BLACKBIO DX has increased by 25.66 % YoY .